Natural Experiments for Translation in Diabetes 2.0 (NEXT-D2) Overview Paper Published in Current Diabetes Report
Natural Experiments for Translation in Diabetes 2.0 (NEXT-D2) published an introductory overview of its research objectives in the February 2018 issue of the Current Diabetes Report. NEXT-D2 is a research collaboration across eight academic centers, including Northwestern University, investigating the relationship between healthcare policy and and diabetes outcomes. The Northwestern University project, led by CHiP Director Dr. Abel Kho and Bernard Black of the Pritzker School of Law, will examine the effect of the Affordable Care Act Medicaid Expansion on diabetes treatment and outcomes in expansion and non-expansion states.
Funded by the CDC, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the NIH, and the Patient-Centered Outcomes Research Institute (PCORI), NEXT-D2 will evaluate a set of natural experiments across three areas: health insurance expansion; healthcare financing and payment models; and innovations in care coordination. The goal is for the experiments to inform future decisions about program and policy implementation to improve the quality of care provided to individuals affected by diabetes.